Perfil de comprador
Terveyden ja hyvinvoinnin laitos
FI- Adjudicaciones
- 31
- Importe total adjudicado
- 60.713.959 €
- Países
- countries.FI
- Última adjudicación
- 20 abr 2026
- Vencen en los próximos 12 meses
- 0
Historial de adjudicaciones
| Fecha | Proveedor | Título | Categoría | Importe | País | Vence | Fuente |
|---|---|---|---|---|---|---|---|
| 20/04/2026 | Pamark Business Oy | Finland – Medical equipments, pharmaceuticals and personal care products – Laboratorio- ja terveydenhuoltotarvikkeiden kilpailutus 2025-2027 (2028-2029) | — | 4,4 M € | FI | — | Ver en TED ↗ |
| 27/01/2026 | Suomen Terveystalo Oy | Finland – Company health services – Työterveys 2024 - 2030 DPS, sisäinen kilpailutus - THL | — | 3,0 M € | FI | — | Ver en TED ↗ |
| 16/12/2025 | BioNordika Oy | Finland – Laboratory reagents – WGS kirjastokitit | — | 269,0 mil € | FI | — | Ver en TED ↗ |
| 18/11/2025 | MIP Pharma Holding GmbH | Finland – Antibacterials for systemic use – Clindamycin 150 mg/ml (4ml per vial/ampoule) | — | 618,0 mil € | FI | — | Ver en TED ↗ |
| 03/10/2025 | Siemens Healthcare Oy | Finland – Imaging equipment for medical, dental and veterinary use – Tietokonetomografialaite (CT-laite/TT-laite) | — | 650,0 mil € | FI | — | Ver en TED ↗ |
| 30/09/2025 | Aguettant Nordic ApS | Finland – Cardiac therapy medicinal products – Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution) | — | 420,0 mil € | FI | — | Ver en TED ↗ |
| 10/09/2025 | Pfizer Oy | Finland – Pharmaceutical products – Clindamycin / Dalacin 15 mg/ml | — | 300,0 mil € | FI | — | Ver en TED ↗ |
| 07/08/2025 | Fabentech SA | Finland – Immune sera and immunoglobulins – Risiinitoksiinin polyklonaalinen vasta-aine | — | 2,8 M € | FI | — | Ver en TED ↗ |
| 02/04/2025 | Sanofi Oy | Finland – Antithrombotic agents – Enoksapariininatrium 100 mg/ml (1 ml esitäytetty ruisku) | — | 2,0 M € | FI | — | Ver en TED ↗ |
| 01/04/2025 | KRKA Finland Oy | Finland – Antibacterials for systemic use – Klaritromysiini 250 mg, Levofloksasiini 500 mg ja Moksifloksasiini 400 mg tabletit/kapselit | Productos farmacéuticos | 677,6 mil € | FI | — | Ver en TED ↗ |
| 29/01/2025 | Roche Oy | Finland – Antivirals for systemic use – Baloxavir marboxil 40 mg tabletit | — | 4,1 M € | FI | — | Ver en TED ↗ |
| 29/01/2025 | MSD Finland Oy | Finland – Vaccines – Ebola-rokote | — | 2,7 M € | FI | — | Ver en TED ↗ |
| 10/01/2025 | Finland – Immunoglobulins – Obiltoksaksimabi - KESKEYTETTY | — | — | FI | — | Ver en TED ↗ | |
| 22/11/2024 | Janssen-Cilag Oy | Finland – Medical equipments, pharmaceuticals and personal care products – Bedakiliinifumaraatti 100 mg | — | 3,7 M € | FI | — | Ver en TED ↗ |
| 22/11/2024 | Viatris Oy | Finland – Pharmaceutical products – Pretomanid 200mg / Dovprela2 | — | 3,0 M € | FI | — | Ver en TED ↗ |
| 22/11/2024 | Tamro Oyj | Finland – Antibacterials for systemic use – Streptomycin 1 g | — | 688,8 mil € | FI | — | Ver en TED ↗ |
| 03/09/2024 | Dr. Franz Köhler Chemie GmbH | Finland – Various medicinal products – Atropiini 10 mg/ml | — | 2,1 M € | FI | — | Ver en TED ↗ |
| 15/05/2024 | HEYL | Finland – Various medicinal products – Preussinsini (Iron(III) hexacyanoferrate(II)) | — | 506,5 mil € | FI | — | Ver en TED ↗ |
| 06/05/2024 | SERB SA | Finland – Various medicinal products – Hydroxocobalamin | — | 2,3 M € | FI | — | Ver en TED ↗ |
| 03/05/2024 | AJ Vaccines A/S | Finland – BCG vaccines (dried) – Tuberkuloosirokote. 2024-2025 | — | 779,0 mil € | FI | — | Ver en TED ↗ |
| 30/04/2024 | Emergent Biosolutions | Finland – Vaccines – Pernaruttorokote. 2023-2024 | — | — | FI | — | Ver en TED ↗ |
| 29/04/2024 | Emergent Biosolutions | Finland – Antisera – Botuliiniantitoksiini, heptavalenttinen (BAT). 2023-2024 | — | — | FI | — | Ver en TED ↗ |
| 16/02/2024 | Illumina Finland Oy | Finland – Laboratory reagents – Reagenssit sekvensointilaitteisiin | — | 1,9 M € | FI | — | Ver en TED ↗ |
| 09/01/2024 | High Metal Oy | Finland – Post-mortem and mortuary equipment and supplies – Ruumiinavauspöydät | — | 144,2 mil € | FI | — | Ver en TED ↗ |
| 20/12/2023 | Seqirus UK Ltd | Finland – Vaccines – Pandeemisen influenssarokotteen ostovaraussopimus | — | 16,3 M € | FI | — | Ver en TED ↗ |
| 13/01/2023 | Finland-Helsinki: Laboratory reagents | — | 500,0 mil € | FI | — | Ver en TED ↗ | |
| 01/04/2022 | Finland-Helsinki: General anti-infectives for systemic use and vaccines | — | 93,4 mil € | FI | — | Ver en TED ↗ | |
| 29/09/2021 | Finland-Helsinki: Vaccines | — | 2,2 M € | FI | — | Ver en TED ↗ | |
| 29/09/2021 | Finland-Helsinki: Vaccines | — | 1,7 M € | FI | — | Ver en TED ↗ | |
| 22/09/2021 | Finland-Helsinki: Vaccines | — | 2,6 M € | FI | — | Ver en TED ↗ | |
| 30/04/2021 | Finland-Helsinki: X-ray devices | — | 137,7 mil € | FI | — | Ver en TED ↗ |